|
|
||||||||
Published online before print June 12, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
promotes definitive maturation of dendritic cells generated by short-term culture of monocytes with GM-CSF and IL-4
Section of Gastroenterology and Division of Clinical Pharmacology, Medizinische Klinik Innenstadt, University of Munich, Germany
@ To whom correspondence should be addressed. E-mail: Eigler{at}lmu.de.
| Abstract |
|---|
Dendritic cells (DC) generated in vitro have to be viable and phenotypically mature to be capable of inducing T cell-mediated immunity after in vivo administration. To facilitate optimization of DC-based vaccination protocols, we investigated whether the cytokine environment and the mode of activation affect maturation and survival of DC derived from monocytes by a short-term protocol. Monocytes cultured for 24 h with granulocyte macrophage-colony stimulating factor and interleukin-4 were stimulated with proinflammatory mediators for another 36 h to generate mature DC. Additional activation with CD40 ligand and interferon (IFN)-
increased viability of DC and promoted definitive maturation as defined by maintenance of a mature phenotype after withdrawal of cytokines. Addition of IFN-
to DC cultures prior to stimulation further enhanced definitive maturation: IFN-
-primed DC expressed high levels of costimulatory molecules and CC chemokine receptor 7 (CCR7) up to 5 days after cytokine withdrawal. Compared with unprimed DC, IFN-
-primed DC displayed equal capacity to migrate upon CCR7 ligation and to prime antigen-specific T helper cell as well as cytolytic T cell responses. In conclusion, we show that optimal maturation and survival of monocyte-derived DC require multiple activation signals. Furthermore, we identified a novel role for IFN-
in DC development: IFN-
priming of monocytes promotes definitive maturation of DC upon activation.
Key Words: differentiation viability priming T cells vaccination immunotherapy
This article has been cited by other articles:
![]() |
V. Veckman and I. Julkunen Streptococcus pyogenes activates human plasmacytoid and myeloid dendritic cells J. Leukoc. Biol., February 1, 2008; 83(2): 296 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Sriram, C. Biswas, E. M. Behrens, J.-A. Dinnall, D. K. Shivers, M. Monestier, Y. Argon, and S. Gallucci IL-4 Suppresses Dendritic Cell Response to Type I Interferons J. Immunol., November 15, 2007; 179(10): 6446 - 6455. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Romieu-Mourez, M. Solis, A. Nardin, D. Goubau, V. Baron-Bodo, R. Lin, B. Massie, M. Salcedo, and J. Hiscott Distinct Roles for IFN Regulatory Factor (IRF)-3 and IRF-7 in the Activation of Antitumor Properties of Human Macrophages Cancer Res., November 1, 2006; 66(21): 10576 - 10585. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |